Insufficient scRNA-seq data for expression of SLC30A2 at single-cell level.
Insufficient scRNA-seq data for expression of SLC30A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1420.73 | 653 / 653 | 83% | 55.62 | 502 / 605 |
pancreas | 100% | 7361.72 | 328 / 328 | 66% | 13.42 | 117 / 178 |
kidney | 98% | 2223.71 | 87 / 89 | 35% | 4.24 | 316 / 901 |
bladder | 71% | 63.95 | 15 / 21 | 46% | 11.98 | 231 / 504 |
adrenal gland | 86% | 148.41 | 222 / 258 | 18% | 5.22 | 42 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.91 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 96% | 12.60 | 77 / 80 |
muscle | 92% | 296.51 | 736 / 803 | 0% | 0 | 0 / 0 |
skin | 66% | 64.94 | 1192 / 1809 | 25% | 2.00 | 117 / 472 |
heart | 81% | 288.89 | 695 / 861 | 0% | 0 | 0 / 0 |
stomach | 20% | 11.50 | 72 / 359 | 34% | 3.17 | 98 / 286 |
ovary | 1% | 0.17 | 1 / 180 | 50% | 5.18 | 215 / 430 |
breast | 27% | 64.46 | 126 / 459 | 23% | 2.08 | 255 / 1118 |
intestine | 11% | 14.81 | 103 / 966 | 32% | 2.99 | 169 / 527 |
prostate | 33% | 27.51 | 80 / 245 | 6% | 0.36 | 30 / 502 |
uterus | 15% | 11.83 | 26 / 170 | 22% | 3.27 | 100 / 459 |
liver | 7% | 2.91 | 15 / 226 | 19% | 3.60 | 77 / 406 |
esophagus | 6% | 3.10 | 80 / 1445 | 8% | 0.53 | 15 / 183 |
lung | 6% | 3.46 | 35 / 578 | 7% | 0.63 | 85 / 1155 |
adipose | 9% | 9.83 | 112 / 1204 | 0% | 0 | 0 / 0 |
brain | 5% | 3.56 | 119 / 2642 | 0% | 0 | 0 / 705 |
blood vessel | 2% | 2.89 | 22 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.11 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0071577 | Biological process | zinc ion transmembrane transport |
GO_0062111 | Biological process | zinc ion import into organelle |
GO_0140915 | Biological process | zinc ion import into zymogen granule |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0140917 | Biological process | zinc ion import into mitochondrion |
GO_0010043 | Biological process | response to zinc ion |
GO_0140916 | Biological process | zinc ion import into lysosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0042589 | Cellular component | zymogen granule membrane |
GO_0005770 | Cellular component | late endosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0010008 | Cellular component | endosome membrane |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
GO_0140826 | Molecular function | zinc:proton antiporter activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC30A2 |
Protein name | Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2) |
Synonyms | ZNT2 |
Description | FUNCTION: [Isoform 1]: Electroneutral proton-coupled antiporter concentrating zinc ions into a variety of intracellular organelles including endosomes, zymogen granules and mitochondria. Thereby, plays a crucial role in cellular zinc homeostasis to confer upon cells protection against its potential cytotoxicity . Regulates the zinc concentration of milk, through the transport of zinc ions into secretory vesicles of mammary cells . By concentrating zinc ions into lysosomes participates to lysosomal-mediated cell death during early mammary gland involution . .; FUNCTION: [Isoform 2]: Electroneutral proton-coupled antiporter mediating the efflux of zinc ions through the plasma membrane. . |
Accessions | Q9BRI3 ENST00000374276.4 [Q9BRI3-2] ENST00000374278.7 [Q9BRI3-1] |